Results 221 to 230 of about 8,162,878 (359)

XXVII. On the electrical resistance of bismuth to alternating currents in a strong magnetic field [PDF]

, 1901
G. C. Simpson
openalex   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance

Journal of Global Antimicrobial Resistance
Objectives: The treatment options available for infections caused by multidrug-resistant Gram-negative pathogens are often limited. Cefiderocol (CFDC) is a novel siderophore cephalosporin that exhibits activity against these pathogens.
Shizuo Kayama, Sayoko Kawakami, Kohei Kondo, Norikazu Kitamura, Liansheng Yu, Wataru Hayashi, Koji Yahara, Yo Sugawara, Motoyuki Sugai   +8 more
doaj  

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis. [PDF]

Pathogens
Bogiel T, Dolska E, Zimna M, Nakonowska K, Krawiecka D, Żebracka R, Pochowski M, Krawczyk A.   +7 more
europepmc   +1 more source

Mediation and resistance [PDF]

, 2011
Cammaerts, Bart
core  

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Molecular Characterization of Plasmid-Mediated Quinolone Resistance Genes in Multidrug-Resistant <i>Escherichia coli</i> Isolated From Wastewater Generated From the Hospital Environment. [PDF]

Environ Health Insights
Banjo OA, Adekanmbi AO, Akinbola OJ, Thomas BT, Ilusanya OAF.   +4 more
europepmc   +1 more source

The potential danger of empiric antimicrobial therapy for nosocomial SBP. [PDF]

, 2016
Antimicrobial Resistance Surveillance in Europe Report 2014, Ariza, Ison, Piano, Runyon   +4 more
core   +1 more source

Genetic Analysis of the Development of Serum Resistance in an Influenza Virus Strain

, 1957
M. J. Edney
openalex   +1 more source

FACTORS IN THE RESISTANCE TO TUBERCULOSIS [PDF]

, 1922

openalex   +1 more source